Suchergebnisse - "Chau, Ian"

PubPharm (22)

1

Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study) : an international, randomized, placebo-controlled, phase 3 trial

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2024

von Kang, Y. | Ryu, M. | Di Bartolomeo, M. | +15

2

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

enthalten in: The New England journal of medicine | 2022

von Doki, Y. | Ajani, J. | Kato, K. | +128

CommentIn: Nat Rev Clin Oncol. 2022 Apr;19(4):219. - PMID 35169266

3

Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer : 2-year update of the randomized phase 3 KEYNOTE-061 trial

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2022

von Fuchs, C. | Özgüroğlu, M. | Bang, Y. | +17

4

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers

enthalten in: Gut | 2021

von Smyth, E. | Vlachogiannis, G. | Hedayat, S. | +30

5

Rationale and design of the POLEM trial : avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised study

enthalten in: ESMO open | 2020

von Lau, D. | Kalaitzaki, E. | Church, D. | +14

6

ACORN : Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UK

enthalten in: Clinical colorectal cancer | 2019

von Khakoo, S. | Chau, I. | Pedley, I. | +10

7

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer : Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

enthalten in: Clinical colorectal cancer | 2019

von Riechelmann, R. | Srimuninnimit, V. | Bordonaro, R. | +19

8

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL) : a double-blind, randomised, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Oncology | 2019

von Fuchs, C. | Shitara, K. | Di Bartolomeo, M. | +122

CommentIn: Lancet Oncol. 2019 Mar;20(3):323-324. - PMID 30718071

9

Association of quality of life with disease characteristics and treatment outcomes in patients with advanced gastric cancer : Exploratory analysis of RAINBOW and REGARD phase III trials

enthalten in: European journal of cancer (Oxford, England : 1990) | 2019

von Chau, I. | Fuchs, C. | Ohtsu, A. | +5

10

Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo : an analysis of the phase 3 REACH study

enthalten in: British journal of cancer | 2018

von Chau, I. | Park, J. | Ryoo, B. | +17